期刊文献+

某院2018年—2019年间8334张门诊患者孕激素类药物处方用药的合理性分析

Analysis on Rationality of 8334 Prescriptions of Pregnant Hormones Medication in Out-patients in a Hospital from 2018 to 2019
下载PDF
导出
摘要 目的:分析医院门诊患者孕激素类药物处方用药的相关因素及其不合理用药原因,为临床合理使用孕激素提供依据。方法:通过医院信息管理系统,调取2018年1月—2019年12月间门诊孕激素类药物用药处方8334张,分析其孕激素类药物用药的合理性以及不合理用药的原因。结果:8334张孕激素类药物用药处方中,主要用于临床诊断为先兆流产、女性不孕症和复发性流产等;其中不合理处方1116张占13.39%,不合理用药类型主要为超剂量用药和重复用药等。结论:医院门诊孕激素类药物处方用药属于基本合理,但仍存在诸多不合理问题,应加强对门诊孕激素类药物的使用管理,以确保其用药的合理性。 Objective:To analyze the related factors and irrational reasons of prescriptions of progesterone drugs in out-patients in hospital,and to provide basis for rational medication of progesterone in clinic.Methods:Through the hospital information system(HIS),8334 prescriptions of Progesterone drugs were collected from out-patient clinics from January 2018 to December 2019 to analyze the rationality of the usage of Progesterone drugs and the reasons for unreasonable medication.Results:Of the 8334 prescriptions for Progesterone drugs,they were mainly used for clinical diagnosis of threatened abortion,female infertility and recurrent abortion.Among them,1,116 were unreasonable prescriptions,accounting for 13.39%,and the unreasonable drug usage types mainly included overdose drug usage and repeated drug medication.Conclusion:The prescription of progesterone drugs in out-patient hospitals is basically reasonable,but there were still many unreasonable problems,so we had to strengthen the management of the medication of progesterone drugs in out-patient hospitals to ensure the rationality of their usage.
作者 潘巧娜 石祥奎 PAN Qiao-na;SHI Xiang-kui(Xuzhou Red Cross Blood Center,Xuzhou Jiangsu 221000,China;Xuzhou Maternal and Child Healthcare Hospital,Xuzhou Jiangsu 221000,China)
出处 《抗感染药学》 2020年第12期1737-1740,共4页 Anti-infection Pharmacy
关键词 孕激素 合理用药 不合理处方 使用管理 Progestogen,rational medication irrational prescription management of the medication
  • 相关文献

参考文献6

二级参考文献79

  • 1安秋月,陈继红,周丽云,吴文静.肌肉注射黄体酮引起臀部脂肪坏死1例[J].牡丹江医学院学报,1992(2):152-153. 被引量:1
  • 2孙青苗.肌内注射黄体酮致局部不良反应相关因素分析[J].中国药物应用于监测,2009,6(5):1234-1235. 被引量:1
  • 3Devoto L, Fuentes A, Kohen P, et al. The human corpus luteum: life cycle and function in natural cycles. Fertil Steril, 2009, 92(3): 1067-79. 被引量:1
  • 4Chabbert Buffet N, Djakoure C, Maitre SC, et ai. Regulation of the human menstrual cycle, Front Neuroendocrinol, 1998, 19(3):151-86. 被引量:1
  • 5Szekeres-Bartho J, Wilczynski JR, Basta P, et al. Role of progesterone and progestin therapy in threatened abortion and preterm labour. Front Biosci, 2008, 13:1981-90. 被引量:1
  • 6Csapo AI, Pulkkinen MO, Wiest WG. Effects of lutectomy and progestreone replacement therapy in early pregnancy patients. Am J Obstet Gynecol, 1973, 115(6):759-65. 被引量:1
  • 7Messinis I, Messini C, Dafopoulos K. Luteal-phase endocrinology. Reprod Biomed Online, 2009, 19(4):4314. 被引量:1
  • 8Fatemi HM. The luteal phase after 3 decades of IVF: what do we know? Reprod Biomed Online, 2009, 19(4):4331. 被引量:1
  • 9Vaisbuch E, de Ziegler D, Leong M, et al. Luteal-phase support in assisted reproduction treatment: real-life practices reported world wide by an updated website-based survey. Reprod Biomed Online, 2014, 28(3):330-5. 被引量:1
  • 10Yanushpolsky E, Hurwitz S, Greenberg L, et al. Patterns ofluteal phase bleeding in in vitro fertilization cycles supple- mented with Crinone vaginal gel and with intramuscular progesterone-impact of luteal estrogen: prospective, randomized study and post hoc analysis. Fertil Steril, 2011, 95(2):617-20. 被引量:1

共引文献236

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部